Continuous Oral Administration of the Superantigen Staphylococcal Enterotoxin C2 Activates Intestinal Immunity and Modulates the Gut Microbiota in Mice
Advanced Science · 2024
DOI: 10.1002/advs.202405039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Wu Gu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Ecology, Chinese Academy of Sciences, 72 WenHua Road, Shenyang, 110016, P. R. China. Hauptthemen laut MEDLINE: Enterotoxins, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation Project of Shenyang City, Zengcheng Entrepreneurship Leadership Team Project.
Abstract (Originalsprache)
Staphylococcal Enterotoxin C2 (SEC2), a classical superantigen, is an antitumor immunotherapy agent. However, the injectable formulation of SEC2 limits its clinical application. Here, it is reported that oral administration of SEC2 activates the intestinal immune system and benefits intestinal health in a mouse model. These results indicate that intact SEC2 is detected in the stomach, intestine, and serum after oral administration. Continuous oral administration of SEC2 activates immune cells in gut‐associated lymphoid tissues, promoting extensive differentiation and proliferation of CD4 + and CD8 + T cells and CD19 + B cells, leading to increased production of cytokines and secretory immunoglobulin A. SEC2 also enhances intestinal barrier function, as demonstrated by an increased villus length/crypt depth ratio and elevated expression of mucins and tight junction proteins. Additionally, SEC2 indirectly influenced gut microbiota, reinforcing potential probiotics and short‐chain fatty acid synthesis. Enhanced differentiation of T and B cells in the spleen, coupled with elevated serum interleukin‐2 levels, suggests systemic immune enhancement following oral administration of SEC2. These findings provide a scientific basis for the development of SEC2 as an oral immunostimulant for immune enhancement and anti‐tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Applied Ecology, Chinese Academy of Sciences, 72 WenHua Road, Shenyang, 110016, P. R. China.
- University of Chinese Academy of Sciences, No.1 Yanqihu East Rd, Huairou District, Beijing, 101408, P. R. China.
- Best Health (Guangdong) Bio-Technology Co., Ltd., Center Building, Minke Park, Xinhui Economic Development Zone, Jiangmen, 529100, P. R. China.
- Key Laboratory of Superantigen Research of Liao Ning Province, No. 72 WenHua Road, Shenyang, 110016, P. R. China.
- Department of Immunology, Shenyang Medical College, No. 146 Huanghe North Street, Shenyang, 110034, P. R. China.
ORCID-Profile: Mingkai Xu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation Project of Shenyang City
- Zengcheng Entrepreneurship Leadership Team Project
- Tianjin Synthetic Biotechnology Innovation Ability Improvement Project
Zitieren
APA
Gu, W., Zhang, H., Zhang, Z., Xu, M., Li, X., Han, Z., Fu, X., Li, X., Wang, X., & Zhang, C. (2024). Continuous Oral Administration of the Superantigen Staphylococcal Enterotoxin C2 Activates Intestinal Immunity and Modulates the Gut Microbiota in Mice. Advanced Science. https://doi.org/10.1002/advs.202405039
Vancouver
Gu W, Zhang H, Zhang Z, Xu M, Li X, Han Z, et al. Continuous Oral Administration of the Superantigen Staphylococcal Enterotoxin C2 Activates Intestinal Immunity and Modulates the Gut Microbiota in Mice. Advanced Science. 2024. doi:10.1002/advs.202405039
BibTeX
@article{Gu2024,
author = {Gu, Wu and Zhang, Huiwen and Zhang, Zhichun and Xu, Mingkai and Li, Xiang and Han, Zhiyang and Fu, Xuanhe and Li, Xu and Wang, Xiujuan and Zhang, Chenggang},
title = {Continuous Oral Administration of the Superantigen Staphylococcal Enterotoxin C2 Activates Intestinal Immunity and Modulates the Gut Microbiota in Mice},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202405039}
}
EUVIMED